PortfoliosLab logoPortfoliosLab logo
BBC vs. BNO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBC vs. BNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and United States Brent Oil Fund LP (BNO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBC achieves a 8.17% return, which is significantly lower than BNO's 86.76% return. Over the past 10 years, BBC has underperformed BNO with an annualized return of 7.60%, while BNO has yielded a comparatively higher 13.38% annualized return.


BBC

1D
-4.90%
1M
-4.81%
YTD
8.17%
6M
20.12%
1Y
123.11%
3Y*
19.82%
5Y*
-2.05%
10Y*
7.60%

BNO

1D
0.76%
1M
-7.65%
YTD
86.76%
6M
83.45%
1Y
89.50%
3Y*
27.10%
5Y*
23.77%
10Y*
13.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. BNO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBC
Virtus LifeSci Biotech Clinical Trials ETF
8.17%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%
BNO
United States Brent Oil Fund LP
86.76%-5.44%9.67%-3.43%35.25%62.34%-38.23%36.01%-15.30%15.43%

Correlation

The correlation between BBC and BNO is -0.23, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.23

Correlation (3Y)
Calculated over the trailing 3-year period

-0.08

Correlation (5Y)
Calculated over the trailing 5-year period

-0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Dec 18, 2014

0.09

The correlation between BBC and BNO shifts across timeframes, from -0.23 (1 year) to 0.09 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBC vs. BNO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC
BBC Risk / Return Rank: 9090
Overall Rank
BBC Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 8989
Sortino Ratio Rank
BBC Omega Ratio Rank: 7979
Omega Ratio Rank
BBC Calmar Ratio Rank: 9696
Calmar Ratio Rank
BBC Martin Ratio Rank: 9494
Martin Ratio Rank

BNO
BNO Risk / Return Rank: 6565
Overall Rank
BNO Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
BNO Sortino Ratio Rank: 5656
Sortino Ratio Rank
BNO Omega Ratio Rank: 6060
Omega Ratio Rank
BNO Calmar Ratio Rank: 8989
Calmar Ratio Rank
BNO Martin Ratio Rank: 5757
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. BNO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and United States Brent Oil Fund LP (BNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BBCBNODifference

Sharpe ratio

Return per unit of total volatility

3.49

2.17

+1.32

Sortino ratio

Return per unit of downside risk

4.11

2.68

+1.44

Omega ratio

Gain probability vs. loss probability

1.48

1.37

+0.11

Calmar ratio

Return relative to maximum drawdown

8.82

5.39

+3.43

Martin ratio

Return relative to average drawdown

28.55

10.23

+18.33

BBC vs. BNO - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 3.49, which is higher than the BNO Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of BBC and BNO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BBCBNODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.49

2.17

+1.32

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.05

0.68

-0.73

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.20

0.37

-0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

0.14

-0.02

Drawdowns

BBC vs. BNO - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, smaller than the maximum BNO drawdown of -87.06%. Use the drawdown chart below to compare losses from any high point for BBC and BNO.


Loading charts...

Drawdown Indicators


BBCBNODifference

Max Drawdown

Largest peak-to-trough decline

-76.85%

-87.06%

+10.21%

Max Drawdown (1Y)

Largest decline over 1 year

-15.10%

-17.87%

+2.77%

Max Drawdown (3Y)

Largest decline over 3 years

-54.45%

-23.75%

-30.70%

Max Drawdown (5Y)

Largest decline over 5 years

-72.44%

-33.70%

-38.74%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

-75.18%

-1.67%

Current Drawdown

Current decline from peak

-30.57%

-12.04%

-18.53%

Average Drawdown

Average peak-to-trough decline

-37.14%

-40.18%

+3.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.66%

9.43%

-4.77%

Volatility

BBC vs. BNO - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 11.21%, while United States Brent Oil Fund LP (BNO) has a volatility of 15.03%. This indicates that BBC experiences smaller price fluctuations and is considered to be less risky than BNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBCBNODifference

Volatility (1M)

Calculated over the trailing 1-month period

11.21%

15.03%

-3.82%

Volatility (6M)

Calculated over the trailing 6-month period

26.65%

36.08%

-9.43%

Volatility (1Y)

Calculated over the trailing 1-year period

35.74%

41.56%

-5.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.31%

35.37%

+3.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.75%

36.68%

+1.07%

BBC vs. BNO - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is lower than BNO's 0.90% expense ratio.


Dividends

BBC vs. BNO - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.57%, while BNO has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.57%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
BNO
United States Brent Oil Fund LP
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


BBC and BNO have a correlation of -0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BNO has higher volatility (15.03%) compared to BBC (11.21%). In terms of maximum drawdown, BBC dropped -76.85% vs BNO's -87.06%.

On 10-year performance, BNO leads with 13.38% vs 7.60% for BBC. On fees, BBC is cheaper at 0.79% per year. On volatility, BBC has been the lower-risk option at 11.21%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, BNO has performed better with a 13.38% return vs 7.60%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BBC is cheaper with a 0.79% expense ratio, compared with 0.90% for BNO.

BBC has the higher dividend yield at 1.57%, compared with 0.00% for BNO.

BBC is categorized as Health & Biotech Equities, while BNO is Oil & Gas. BBC tracks LifeSci Biotechnology Clinical Trials Index, while BNO tracks Front Month Brent Crude Oil. They also come from different issuers: Virtus Investment Partners and Concierge Technologies. Their fees differ too: 0.79% for BBC and 0.90% for BNO.

BBC currently has the higher Sharpe Ratio (3.49 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBC and BNO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer